Skip to content
★ Sign in to follow
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. logo

Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Stock: price and insider trades · China

澳华内镜

CN·Mcap CN¥3.4BHealth Care

No insider purchase over the last 90 days. The latest, by 施晓江, was filed 08 Jan 2025.

Shanghai Aohua Photoelectricity Endoscope Co., Ltd.: what insiders have been doing

Every trade that managers of Shanghai Aohua Photoelectricity Endoscope Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. In the past year (5 November 2025 to 5 November 2026), 3 filings came from 1 insider.

No insider bought on the market over the period, while 1 insider filed 3 sales totalling €2.6M. The largest single trade was a sale of €1.1M by 顾小舟, published on 1 December 2025.

Compared with its exchange (514 companies, median 2 filings), a count of 3 filings is above the norm. The full history, which starts in 2024, counts 1 purchase against 4 sales.

Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
5
Thresholds
n/a
Buy Volume
€5,889
1 ops. · all time
Sell Volume
€3M
4 ops. · all time

Who traded when

BuySale
顾小舟3 sales
施晓江1 buy

Since the insiders bought

  • Filed 08 Jan 2025 · 669 days ago · €5,889
    +22.9%
    Entry CN¥39.21 · Close at T+365 CN¥48.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,489 of 26,912 companies
30.8
score / 100
Value
20
Quality
42
FCF yld-4.5%
Earn yld0.3%
EV/EBITDA46.2x
ROE-2.6%
Gross mgn65%
Net mgn1.5%
Debt/EBITDA4.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥24.97
Analyst consensus
3 analysts
·
CN¥38.00Target CN¥45.56(+82%)CN¥50.00
Income statement
RevenueCN¥773.9M
Gross profitCN¥504.9M65% margin
EBITDACN¥80.2M10% margin
Net incomeCN¥11.5M-4.2% margin
Valuation
PER (trailing)211.4x
PER (forward)40.6x
P/Book2.7x
Beta-0.34
Balance sheet & cash
Market capCN¥3.4B
Total debtCN¥340.3M
Free Cash Flow-CN¥150.7M
Debt / Equity33%
Profitability & ownership
ROE-2.6%
ROA-1.9%
% insiders32.9%
% institutions20.3%
Last declaration on 16 December 2025
Declarations5 total
  • ▼
    董事Executives
    3M CNY8SSE
    59,084 shares12.8% of flowA股XSHGSSE:273000000037591420
  • ▼
    董事Executives
    9M CNY11SSE
    200,000 shares43.5% of flowA股XSHGSSE:273000000018963300
  • ▼
    董事Executives
    9M CNY11SSE
    200,000 shares43.7% of flowA股XSHGSSE:173000009853321440
  • ▲
    高级管理人员Executives
    44,635 CNY19SSE
    1,130 shares100.0% of flowA股XSHGSSE:173000008412379600
    Canonical exit: 8 Apr 2025 (T+90)
  • ▼
    核心技术人员Executives
    1M CNY10SSE
    19,518 shares100.0% of flowA股XSHGSSE:173000008172939740

5 of 5 declarations

About Shanghai Aohua Photoelectricity Endoscope Co., Ltd.

澳华内镜 is a company specializing in the development and manufacturing of medical instruments, particularly endoscopes. It is listed on the Shanghai Stock Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations